Back

Autoimmune uveitis market estimated at $1.2 billion in 2025

Verifying
  • DelveInsight published an autoimmune uveitis market report covering seven major markets through 2036.
  • USD 1.2 billion was the estimated 2025 market size, with nearly 673,000 diagnosed cases.
  • Novaliq, Celltrion, Priovant Therapeutics and VivaVision Biotech reported developments between April 2025 and January 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.